Projection of Revenue Growth:
The Liquid Biopsy Market was valued at US$ 2.55 Bn. in 2023. Global Liquid Biopsy Market size is expected to grow at a CAGR of 20.9 % through the forecast period.
Liquid Biopsy Market Overview
The report provides a detailed overview of the Liquid Biopsy Market, outlining market shares, key drivers, restraints, and growth opportunities. It covers both international and domestic markets, offering insights into the overall landscape, trade dynamics, and important areas of development.
Details insights on this market, request for methodology here:https://www.maximizemarketresearch.com/request-sample/3261/
Liquid Biopsy Market Report Scope and Research Methodology
The research for this report offers a comprehensive analysis of the global Liquid Biopsy Market, addressing both value and volume aspects and providing forecasts for the projected period. It includes regional and country-level analyses to identify recent and future growth trends, opportunities, and market contributions. Key metrics such as Compound Annual Growth Rate (CAGR), market size, value, volume, revenue, and sales are detailed. Each industry segment is assessed based on growth rate and market share. The report also features an in-depth analysis of key market players by region, highlighting their revenue, financial status, and technological advancements, offering valuable insights into the competitive landscape. A bottom-up approach ensures precise estimation of the market size.
Liquid Biopsy Market Regional Insights
The Liquid Biopsy Market is segmented into major regions—North America, Europe, Asia Pacific, the Middle East and Africa, and South America—offering a detailed view of its global presence and regional influence.
Liquid Biopsy Market Segmentation
by Product
Assay Kits
Instruments
by Technology
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)
by Application
Cancer
Non- Cancer
by End User
Reference Lab
Hospitals
Liquid Biopsy Market Key Players
1. F. Hoffmann-La Roche Ltd. (Switzerland)
2. Myriad Genetics, Inc. (US)
3. QIAGEN N.V. (Netherlands)
4. Thermo Fisher Scientific, Inc. (US)
5. Guardant Health, Inc. (US)
6. MDxHealth SA (Belgium)
7. Exact Sciences Corporation (US)
8. Illumina Inc. (US)
9. Sysmex Inostics (US)
10. Bio-Rad Laboratories, Inc. (US)
11. Biocept, Inc. (US)
12. NeoGenomics, Inc. (US)
13. ANGLE plc. (UK)
14. Menarini-Silicon Biosystems (Italy)
15. Vortex Biosciences, Inc. (US)
16. Exosome Diagnostics, Inc. (US)
17. Agena Bioscience, Inc. (US)
18. MedGenome Inc. (US)
19. Epigenomics AG (Germany)
20. Personal Genome Diagnostics, Inc. (US).
Please Contact Us On link:https://www.maximizemarketresearch.com/market-report/global-liquid-biopsy-market/3261/
Conclusion:
The Global Liquid Biopsy Market, valued at USD 2.55 billion in 2023, is set to experience robust growth at a CAGR of 20.9%, reaching USD 9.63 billion by 2030. This expansion is driven by the increasing prevalence of cancer, the advantages of non-invasive diagnostic methods, and advancements in technologies such as Next-Generation Sequencing (NGS) and exosome-based assays. Despite challenges like lower sensitivity of certain tests and an unclear reimbursement landscape, the market is bolstered by growing demand for early cancer detection and personalized treatment. North America leads the market, supported by substantial investments and regulatory approvals, while technological innovations and rising awareness contribute to global growth. The market's evolution reflects a significant shift towards more accessible and precise cancer diagnostics.
Explore our top-performing reports on the latest trends:
Global IT Asset Disposition (ITAD) Market https://www.maximizemarketresearch.com/market-report/global-it-asset-disposition-market/31593/
Global Automation-as-a-Service Market https://www.maximizemarketresearch.com/market-report/automation-service-market/3070/
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com
Comments
0 comment